文献速递痛风与晶体性关节病

超声预测痛风发作:一项为期12个月的前瞻性观察性研究

Ultrasonography in the prediction of gout flares: a 12-month prospective observational study.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

这项为期12个月的前瞻性观察性单中心研究连续纳入接受降尿酸治疗至少6个月的痛风患者,采用巢式病例对照分析,评估提示单钠尿酸盐(MSU)沉积的超声表现和超声检出的炎症(能量多普勒信号)是否预测12个月内的痛风发作。结果显示基线MSU沉积总评分与能量多普勒评分与发作发生及发作次数独立相关。

要点

  • 基线超声提示MSU沉积的负担与能量多普勒信号在发作组高于无发作组。
  • 基线MSU沉积总评分与能量多普勒评分与12个月内痛风发作发生独立相关。
  • 基线MSU沉积总评分与能量多普勒评分与12个月内痛风发作次数独立相关。

核心结论

  • 基线超声提示MSU沉积的表现和超声检出的炎症是12个月内痛风发作的独立预测因素。

研究设计与样本

  • 为期12个月的前瞻性观察性单中心研究,连续纳入接受降尿酸治疗至少6个月前的痛风患者,并进行巢式病例对照分析。
  • 超声评估部位包括肘、腕、第二掌指关节、膝、踝和第一跖趾关节。
  • 病例为随访期内至少有一次发作者,对照为自我报告无痛风发作者。

主要发现

  • 81例痛风患者入组,71例完成研究。
  • 71例中30例(42.3%)在12个月内至少经历一次发作,发作次数中位数为2.0次。
  • 基线时病例组MSU沉积超声总评分高于对照组(6.7 ± 4.7 vs 2.9 ± 2.6,P = 0.01)。
  • 基线时病例组能量多普勒评分高于对照组(3.73 ± 3.53 vs 0.82 ± 1.44,P < 0.01)。

关键数值与推荐

  • MSU沉积表现(聚集、双轨征和痛风石)按风湿病学结局测量定义判定为存在或不存在。
  • 能量多普勒信号采用半定量评分,每种超声表现计算总和评分。
  • 多因素分析中,MSU沉积总评分与发作发生的校正比值比为1.75(95%CI:1.26,2.43)。
  • 多因素分析中,能量多普勒评分与发作发生的校正比值比为1.63(95%CI:1.12,2.40)。
  • 多因素分析中,MSU沉积总评分与发作次数的校正发病风险比为1.17(95%CI:1.08,1.26),能量多普勒评分与发作次数的校正发病风险比为1.29(95%CI:1.19,1.40)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether US findings indicating MSU deposits and US-detected inflammation (i.e. power Doppler signal) predict gout flares over 12 months. METHODS: Gout patients on urate-lowering therapy for at least the preceding 6 months were enrolled consecutively in this 12-month prospective, observational, single-centre study. A nested case-control analysis was performed. Cases were participants with at least one flare in the follow-up period, while controls did not self-report any gout flare. The US assessment included elbows, wrists, second MCP joints, knees, ankles, and first MTP joints. The US findings indicating MSU deposits [i.e. aggregates, double contour (DC) sign and tophi] were identified as present/absent according to the Outcome Measure in Rheumatology definitions. Power Doppler signal was scored semiquantitatively. Summated scores were calculated for each US finding. RESULTS: Eighty-one gout participants were enrolled, and 71 completed the study. Thirty (42.3%) of 71 participants experienced at least one flare over 12 months, with a median of 2.0 flares. Cases had a greater US burden of MSU deposits (6.7 ± 4.7 vs 2.9 ± 2.6, P = 0.01) and power Doppler signal (3.73 ± 3.53 vs 0.82 ± 1.44, P < 0.01) than controls, at baseline. The baseline US scores indicating MSU deposits and US-detected inflammation were significantly associated with the occurrence (total MSU score, adjusted odds ratio:1.75, 95% CI: 1.26, 2.43; power Doppler score, adjusted odds ratio: 1.63, 95% CI: 1.12, 2.40) and the number (total MSU score, adjusted incidence risk ratio: 1.17, 95% CI: 1.08, 1.26; power Doppler score, adjusted incidence risk ratio: 1.29, 95% CI: 1.19, 1.40) of flares over 12 months in multivariate analyses. CONCLUSIONS: Baseline US findings indicating MSU deposits and US-detected inflammation are independent predictors of gout flares over 12 months.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Cipolletta E, Abhishek A, Di Battista J, et al. Ultrasonography in the prediction of gout flares: a 12-month prospective observational study. Rheumatology (Oxford). 2023. PMID: 35920773. doi:10.1093/rheumatology/keac367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。